Medipost

At a glance

Medipost filed 47 disclosures in the last 12 months, including 4 5% holder and 4 issuance. The most recent key filing was on Jan 20: A major holder's stake rose from 0.00% to 50.71% (conversion/exercise).

Revenue for 2025 was ₩73.7B, up 4.2% on 2024. It made an operating loss of ₩68B. Debt was 73% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩38.2B and operating loss of ₩41.2B.

The 2025 annual report lists 684 employees with an average tenure of 5.4 years and average pay of ₩61.7M, #1050 of 2,191 listed companies by average pay. Its 7 directors and auditors were paid ₩102M each on average. It paid no cash dividend for 2025. 스카이메디 유한회사 and related parties held 47.21% at year end.

Of 4 recent 5%+ holder reports, 3 raised and 1 cut a stake; the largest stake reported was 53.77% on Jan 13.

From the 2025 annual report

Staff: 684 (290 men, 394 women), of whom 84 on fixed-term contracts. Total pay for the year: ₩21.1B. Directors and auditors: 7, paid ₩713M in total.

No cash dividend was paid for 2025.

Largest shareholder

스카이메디 유한회사 holds 22.28%; with 4 related parties the group holds 47.21% of common shares at year end (from 35.62% at the start of the year).

Auditor: 한울회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

5%+ holder reports